<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR42" class="ref">
 <label class="label">42.</label>
 <element-citation publication-type="journal" class="element-citation">
  <person-group person-group-type="author" class="person-group">
   <name class="name">
    <surname class="surname">Bisson</surname>
    <given-names class="given-names">J</given-names>
   </name>
   <name class="name">
    <surname class="surname">McAlpine</surname>
    <given-names class="given-names">JB</given-names>
   </name>
   <name class="name">
    <surname class="surname">Friesen</surname>
    <given-names class="given-names">JB</given-names>
   </name>
   <name class="name">
    <surname class="surname">Chen</surname>
    <given-names class="given-names">S-N</given-names>
   </name>
   <name class="name">
    <surname class="surname">Graham</surname>
    <given-names class="given-names">J</given-names>
   </name>
   <name class="name">
    <surname class="surname">Pauli</surname>
    <given-names class="given-names">GF</given-names>
   </name>
  </person-group>
  <article-title class="article-title">Can invalid bioactives undermine natural product-based drug discovery?</article-title>
  <source class="source">J Med Chem.</source>
  <year class="year">2016</year>
  <volume class="volume">59</volume>
  <fpage class="fpage">1671</fpage>
  <lpage class="lpage">1690</lpage>
  <pub-id pub-id-type="doi" class="pub-id">10.1021/acs.jmedchem.5b01009</pub-id>
  <?supplied-pmid 26505758?>
  <pub-id pub-id-type="pmid" class="pub-id">26505758</pub-id>
 </element-citation>
</ref>
